RAPP (rapportrx.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Rapport Therapeutics Inc (RAPP)

Rapport Therapeutics, Inc. (RAPP) is a biotech developer creating high-precision treatments for pain and epilepsy by targeting brain receptors without side effects. This market price chart, with a value of 3.11, clearly illustrates the asset's quotes. Business revenues will be based on the sale of targeted drugs to patients and insurance funds. The company is currently completing key tests of breakthrough small molecules for the therapy of focal epilepsy.

RAPP Rapport Corp: Nilai Pasar marang Nilai Buku ing interval 08.06.2024 - 28.10.2026

Rincian metrik keuangan lan pasar Rapport Therapeutics Inc (RAPP)

- rega lan prakiraan konsensus rega:
Bagan rega Rapport Therapeutics, Inc.|RAPP - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Nilai pasar Rapport Pharma|RAPP - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Rapport Therapeutics|RAPP - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku rapportrx.com|RAPP - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Rapport Therapeutics, Inc.|RAPP - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Rapport Pharma|RAPP - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Rapport Pharma|RAPP - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Rapport Therapeutics
Analisis wiwitan perusahaan:Rapport Therapeutics, Inc. - RAPP
Produk asli Rapport Pharma

The prospects of Rapport Therapeutics, Inc. (RAPP) depend on the success of clinical trials for CNS drugs and patent protection, making intellectual capital a key asset. The price-to-book value ratio trend reflects the market's revaluation of these intangible advantages relative to net assets, showing the premium investors are willing to pay for the business's future growth potential beyond its current book value.

Pesaing utama

Rasio Nilai Pasar marang Nilai Buku Jazz Pharmaceuticals (JAZZ)|CYTK (cytokinetics.com) - Kapitalisasi Pasar marang Aset Bersih|Rasio Nilai Pasar marang Nilai Buku PTC Therapeutics PTCT|Kapitalisasi Pasar marang Aset Bersih Scholar Rock, Inc.|Centessa Pharmaceuticals PLC (CNTA) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Dyne Corp (DYN)|Rasio Kapitalisasi Pasar marang Nilai Buku EWTX (Edgewise Therapeutics)|alumis.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Zevra Therapeutics, Inc. (ZVRA)|CTNM: Nilai Pasar marang Nilai Buku|LRMR (Larimar Pharma) - Rasio Nilai Pasar marang Nilai Buku|Capricor Therapeutics, Inc. (CAPR) - Rasio Kapitalisasi marang Aset Bersih|TRDA (Entrada Therapeutics) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku channeltherapeutics.com (PTHS)|MediciNova, Inc. (MNOV) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku SER (Serina Therapeutics Inc)|BTAI - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku ProMIS Neurosciences Inc. PMN|APUS (Apimeds) - Rasio Kapitalisasi Pasar marang Nilai Buku|AEON Biopharma (AEON) - Koefisien Nilai Pasar marang Nilai Buku|NLSP: Rasio Kapitalisasi marang Aset Bersih|BNOX (Bionomics) - Rasio Kapitalisasi Pasar marang Nilai Buku|HUGE - Rasio Nilai Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku RETA